News from the healthcare data industry
NEW YORK and OTTAWA, ON, Jan. 4, 2022 /PRNewswire/ — Aetion, the leading regulatory-grade real-world evidence (RWE) technology provider, today announced that it has acquired Replica Analytics, a pioneer in using artificial intelligence (AI) for synthetic health data generation. Replica’s AI technology generates synthetic, privacy-protected copies of real-world data (RWD) that preserve the integrity…
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced a partnership with Illumina, Inc. (NASDAQ:ILMN), aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health…
By Tamra Sami PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) has undertaken a massive effort to reform its drug and device regulations, and as it pulls into the homestretch with those reforms, it is setting its sights to postmarketing efforts that include adverse event reporting, conformity assessments, patient-reported outcomes and a universal…
31 Dec 2021 NEWS Vibha Sharma Executive Summary The UK Medicines and Healthcare products Regulatory Agency has finalized the first part of a series of new guidance documents addressing issues around using real-world data in support of regulatory submissions. Source: AlamyUSE OF RWD CAN MAKE CLINICAL TRIALS MORE COST-EFFECTIVE The UK…
During the prescribing process, a physician’s ability to accurately and reliably match the most appropriate therapy option to the patient in question is limited by the quantity and quality of available clinical information. Although randomized clinical trials are considered the gold standard for establishing the safety and efficacy of prescription…
ROCHESTER, Mich., Dec. 29, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”)(Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced its Evidence-based Physician Engagement solution has been recognized as one of the most innovative products of the year for life sciences by PM360. OptimizeRx’s Evidence-Based Physician…
Bill Evans, chief marketing officer at Komodo Health, joins Steve Madden live from the floor of the HLTH conference to discuss how the company’s Healthcare Map is serving as a source for patient data. MM+M Staff December 1, 20211:00 PM
Author: Dr. Matthew Roe and Rebecca HancockDecember 2021BackTwitterFacebookLinkedIn Verana Health recently shared comments with the Food and Drug Administration sharing our support for its draft guidance document, “Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry.” …
The companies will reportedly focus on exploring real-world evidence and conducting clinical trials through G42 Healthcare’s Contract Research Organisation, IROS.By Rachel McArthurDecember 24, 202108:37 AM Credit: iStock AstraZeneca has teamed up with one of Abu Dhabi’s leading healthtech companies to boost clinical research and diagnostics’ frameworks in the United Arab…
Sensyne Health PLC (AIM:SENS), the clinical artificial intelligence (AI) company, announced two new partnership deals. The first is a one-year agreement with Exscientia “to leverage the deep learning AI capabilities of the Sensyne platform to study real-world health data,” a statement said. Exscientia will make an upfront payment for four…